首页> 美国卫生研究院文献>BMC Nephrology >An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study

【2h】

An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study

机译：从常规初级保健数据中识别慢性肾脏疾病病例的本体论方法：一项横断面研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAccurately identifying cases of chronic kidney disease (CKD) from primary care data facilitates the management of patients, and is vital for surveillance and research purposes. Ontologies provide a systematic and transparent basis for clinical case definition and can be used to identify clinical codes relevant to all aspects of CKD care and its diagnosis.

机译：背景技术从初级保健数据中准确识别出慢性肾脏病（CKD）病例有助于患者的管理，并且对于监视和研究目的至关重要。本体为临床病例定义提供了系统且透明的基础，可用于识别与CKD护理及其诊断的各个方面相关的临床规范。

著录项

期刊名称 BMC Nephrology
作者
Nicholas I. Cole; Harshana Liyanage; Rebecca J. Suckling; Pauline A. Swift; Hugh Gallagher; Rachel Byford; John Williams; Shankar Kumar; Simon de Lusignan;
展开▼
作者单位

展开▼
年(卷),期 2018(19),-1
年度 2018
页码 85
总页数 6
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病） ; 小儿泌尿科学 ; 肾疾病 ;
关键词
Chronic kidney disease Epidemiology Ontology eGFR Proteinuria;

机译：慢性肾脏病;流行病学;本体论;eGFR;蛋白尿;

相似文献

外文文献
中文文献
专利

1. An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study [J] . Nicholas I. Cole, Harshana Liyanage, Rebecca J. Suckling, BMC Nephrology . 2018 ,第1期

机译：从常规初级保健数据中识别慢性肾脏疾病病例的本体方法：一项横断面研究
2. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25?mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial [J] . Nathan R Hill, Daniel Lasserson, Ben Thompson, Trials . 2014 ,第1期

机译：醛固酮受体拮抗作用在慢性肾脏病（BARACK D）试验中的益处-一项多中心，前瞻性，随机，开放，盲点终点研究，为期3个月，研究对象为2,616名3b期慢性肾脏病初级保健患者，以比较螺内酯25毫克/天的常规治疗对死亡率和心血管疾病的疗效，与常规治疗相比，每天一次：随机对照试验的研究方案
3. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data [J] . Olga Dmitrieva, Simon de Lusignan, Iain C Macdougall, BMC Nephrology . 2013 ,第1期

机译：慢性肾脏病初级保健患者贫血的关联：改善慢性肾脏病（QICKD）试验数据质量的横断面研究
4. Urine Arsenic and Chronic Kidney Disease: Cross-sectional and Prospective Evidence from the Strong Heart Study [C] . Laura Zheng, Jason G. Umans, Fawn Yeh, Annual conference of the International Society of Exposure Science . 2014

机译：尿砷和慢性肾脏疾病：强心研究的横断面和前瞻性证据
5. Understanding, evaluating and enhancing electronic medical record adoption in a primary caresetting: A programme to improve electronic medical record data quality and its effect on familypractice provision of incentivized and enhanced care for chronic disease patients [D] . Bowen, Michael. 2013

机译：了解，评估和增强在初级护理环境中采用电子病历的方案：一项旨在提高电子病历数据质量及其对家庭实践的激励措施的计划，该方案为慢性病患者提供激励和加强护理
6. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre prospective randomised open blinded end-point 36-month study of 2616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial [O] . Nathan R Hill, Daniel Lasserson, Ben Thompson, 2014

机译：醛固酮受体拮抗作用在慢性肾脏病（BARACK D）试验中的益处-一项多中心前瞻性随机开放盲点终点研究为期3个月研究对象为2616名3b期慢性肾脏病初级保健患者以比较螺内酯25 mg每日一次除常规治疗对死亡率和心血管结局的疗效与仅常规治疗相比：一项随机对照试验的研究方案
7. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial [O] . Hill, NR, Lasserson, D, Thompson, B, 2014

机译：醛固酮受体拮抗作用在慢性肾脏病（BARACK D）试验中的益处–一项多中心，前瞻性，随机，开放，盲点终点研究，为期3个月，研究对象为2,616名3b期慢性肾脏病初级保健患者，以比较螺内酯25 mg除常规治疗对死亡率和心血管结局的每日疗效与单独常规治疗相比，每天一次：随机对照试验的研究方案

An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study

摘要

著录项

相似文献

相关主题

期刊订阅